Literature DB >> 1815455

Growth hormone therapy in adults with growth hormone deficiency.

P H Sönksen1, R C Cuneo, F Salomon, G McGauley, C M Wiles, P Wilmshurst, C Byrne, R Hesp, C Lowy, A Weissberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1815455     DOI： 10.1111/j.1651-2227.1991.tb12064.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand Suppl        ISSN： 0300-8843


× No keyword cloud information.
  4 in total

Review 1.  Quality-of-life assessment of adults with growth hormone deficiency. Implications for drug therapy.

Authors:  S P McKenna; L C Doward
Journal:  Pharmacoeconomics       Date:  1994-11       Impact factor: 4.981

2.  Antioxidative mechanisms and plasma growth hormone levels: potential relationship in the aging process.

Authors:  H M Brown-Borg; A M Bode; A Bartke
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

3.  Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients.

Authors:  Abdishakur M Abdulle; Michael P T Gillett; Samra Abouchacra; Sufyan M Sabri; Mona Al Rukhaimi; Enyioma N Obineche; Jaipaul Singh
Journal:  Mol Cell Biochem       Date:  2007-03-27       Impact factor: 3.396

4.  Mitochondrial oxidant generation and oxidative damage in Ames dwarf and GH transgenic mice.

Authors:  H Brown-Borg; W T Johnson; S Rakoczy; M Romanick
Journal:  J Am Aging Assoc       Date:  2001-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.